showed a trendP =0.1475
14 Though limited by small numbers, IL-2/SIR/TAC patients who prematurely discontinued IL-2 before day +90 (n=6) actually showed a trend toward less acute GvHD compared to protocol-adherent individuals (n=14) [16.7% (95%CI:0.001–77.7) vs. 50% (95%CI: 27.8–77.1), P =0.1475].